CV vs STE · rev $3.5M vs P/E 25, rev $5.46B
CapsoVision, Inc. Common Stock (CV) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
CV currently screens at market cap $359.2M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the CV and STE stock pages for the full models.
Not investment advice.